Nobel Prize for microRNA

Victor Ambros and Gary Ruvkun won this year’s Physiology or Medicine award for the discovery of microRNA and its role in post-transcriptional gene regulation.

Written byDanielle Gerhard, PhD and Sneha Khedkar
| 4 min read
Black and gold sketch of Victor Ambros and Gary Ruvkun, the 2024 Nobel Prize laureates.
Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Victor Ambros, a developmental biologist at the University of Massachusetts Chan Medical School, and Gary Ruvkun, a geneticist at Harvard Medical School, won this year’s Nobel Prize in Physiology or Medicine “for the discovery of microRNA and its role in post-transcriptional gene regulation,” the Nobel Assembly at the Karolinska Institute announced today (October 7). This discovery revealed a fundamental principle governing how gene activity is regulated.

“microRNAs are important for our understanding of embryological development, normal cell physiology, and diseases such as cancer,” said Olle Kämpe, vice chair of the 2024 Nobel Committee for Physiology or Medicine.

Every somatic cell in the body has the same set of genes, yet a brain cell is different from a liver cell. Differences in gene regulation across development drive cell diversity and the emergence of specialized cellular functions. By the early 1990s, scientists thought that they understood the basic principles of gene regulation, but then a series of unusual findings emerged.

Ambros and Ruvkun first met in the late 1980s when they were both postdoctoral researchers in the laboratory of the famous worm biologist Robert Horvitz at the Massachusetts Institute of Technology. They were studying the larval stages of Caenorhabditis elegans development. Horvitz’s team previously found that lin-4 mutants exhibited developmental abnormalities, such as missing structures and cell types.1 After he joined the group, Ambros discovered that lin-14 mutants exhibited a complete absence of larval programs and that lin-4 is responsible for turning off lin-14.2,3

Ambros and Ruvkun wanted to learn more about the functions and products of these genes and how lin-4 blocks lin-14 activity. They decided to divide and conquer: Ambros would take on lin-4, while Ruvkun tackled lin-14.

In his new laboratory at Harvard University, Ambros and his team cloned the lin-4 gene. But they noticed something unusual: the gene did not encode a protein. Instead, it produced two short transcripts, one of which was only 22 nucleotides long.4 Nearby, in his own laboratory at Harvard Medical School, Ruvkun came across another unexpected finding. Instead of interfering with lin-14 mRNA production, lin-4 appeared to interfere with protein production.5 Furthermore, he demonstrated how a small section of the lin-14 mRNA was necessary for lin-4-mediated regulation.

During one late-night phone call, Ambros and Ruvkun pored over their sequences in search of answers to these mysterious observations. They noticed that the small lin-4 transcript matched complementary sequences in the 3’ untranslated region of the lin-14 mRNA. The duo appeared to have discovered a new principle of post-transcriptional gene regulation orchestrated by a small, unknown type of RNA. In 1993, they published their findings in the same issue of Cell.4,5 However, it was not met with much fanfare from the scientific community.

“At the time, there was no framework for thinking about a very short antisense transcript,” Ambros previously said in a 2022 interview with Drug Discovery News.

Many researchers also chalked it up to a worm oddity. “There was always a view that worms were quirky and weird,” Ruvkun said in the interview with Drug Discovery News.

The tiny RNA remained shrouded in mystery until 2000 when Ruvkun and his team discovered another short 21-nucleotide RNA encoded by the gene let-7 which was involved in worm development.6 However, unlike the worm-specific lin-4, let-7 is evolutionarily conserved; it is found not only in sea sponges and worms, but importantly, also in mice and humans.7

Continue reading below...

Like this story? Sign up for FREE Genetics updates:

Latest science news storiesTopic-tailored resources and eventsCustomized newsletter content
Subscribe

“A postdoc in my lab ran these northern blots on zoos of RNA, proving that these tiny RNAs were universal to animals,” Ruvkun said in the interview with Drug Discovery News.

If there were two of these small RNAs, the researchers reasoned that there must be more. Sure enough, in 2001, three papers published in the same issue of Science uncovered dozens of small RNAs, which the researchers called microRNAs.8-10

Nearly a decade after the discovery of the first microRNA, other scientists began to recognize this new type of regulatory RNA. Since then, aided by advances in molecular biology and sequencing, scientists have discovered thousands of microRNA genes in the human genome that orchestrate cell and tissue development and cell physiology. There is also a growing appreciation of how mutations in genes encoding microRNAs lead to conditions such as congenital hearing loss, eye and skeletal disorders, neurodegenerative diseases, and cancer.

Ambros and Ruvkun’s seminal discovery of microRNA not only opened the door to a new dimension of gene regulation observed across the evolutionary sphere, but also highlights how studying simple models can lead to discoveries that are relevant to human health and disease.

Related Topics

Meet the Author

  • Black and white photo of Danielle Gerhard

    Danielle is a Senior Editor at The Scientist. She earned her PhD in psychology and behavioral neuroscience from Yale University and completed a postdoctoral fellowship in neuroscience Weill Cornell Medicine. Her research explored the cellular and molecular mechanisms of stress and depression across development. She has served as editor-in-chief of the Yale Journal of Biology and Medicine, contributed stories to BioTechniques News and Drug Discovery News, and engaged in various science outreach initiatives across Connecticut and NYC.

    View Full Profile
  • Sneha Khedkar

    Sneha Khedkar is an Assistant Editor at The Scientist. She has a Master’s degree in biochemistry, after which she studied the molecular mechanisms of skin stem cell migration during wound healing as a research fellow at the Institute for Stem Cell Science and Regenerative Medicine in Bangalore, India. She has previously written for Scientific American, New Scientist, and Knowable Magazine, among others.

    View Full Profile
Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026, Issue 1

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs
Graphic of three DNA helices in various colors

An Automated DNA-to-Data Framework for Production-Scale Sequencing

illumina
Exploring Cellular Organization with Spatial Proteomics

Exploring Cellular Organization with Spatial Proteomics

Abstract illustration of spheres with multiple layers, representing endoderm, ectoderm, and mesoderm derived organoids

Organoid Origins and How to Grow Them

Thermo Fisher Logo

Products

nuclera logo

Nuclera eProtein Discovery System installed at leading Universities in Taiwan

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control

Biotium Logo

Biotium Launches GlycoLiner™ Cell Surface Glycoprotein Labeling Kits for Rapid and Selective Cell Surface Imaging

Colorful abstract spiral dot pattern on a black background

Thermo Scientific X and S Series General Purpose Centrifuges

Thermo Fisher Logo